CBO Sanford-Burnham Medical Research Inst.; Enterprise Partners Venture Capital; CorSolutions Medical Corp.; MyoPoint
Kevin Barrett (BSc)
Sr VP Corporate Development, Gilson / Bus. Dev. IDEX Health & Science / CEO Innovadyne Technologies / Dir. Anachem
Frank Graziano (MD PhD)
Dr. Frank Graziano is the drive behind our HIV Global Health work. Dr. Graziano was on the forefront of combating HIV/AIDS during its initial prevalence here in the U.S. and has been instrumental in combating and raising awareness internationally. His international experience is in Uganda where he has focused on research, education and clinical treatment of HIV/AIDS. Given his decades of experience in Uganda, Dr. Graziano brings a vast in-country knowledge and is able to guide us through developing meaningful technologies to improve clinical care.
Joshua M. Lang (MD)
Dr. Josh Lang is a medical oncologist, clinical trialist and laboratory researcher at the University of Wisconsin Carbone Cancer Center. His overarching goal is to understand therapeutic resistance in cancer and develop new treatment strategies that target these mechanisms. Dr. Lang has played a critical role in developing and advancing our ESP based rare cell isolation platform.